Coral Laboratories Ltd
NSE: BSE: 524506
₹443.70
(1.04%)
Wed, 11 Mar 2026, 04:10 am
Market Cap1.59B
PE Ratio11.33
Dividend0.34
Health Technology
Pharmaceuticals: Other
24.5KCompany History
1981
- Coral Laboratories P Ltd was incorporated.
1993
- The company was converted into a Public Ltd company.
2000
- The company received a WHO GMP Certificate for the Baroda Plant.
- The company received an ISO 9002 Certificate.
2001
- The company entered global marketing and started exporting.
- The company renewed its WHO GMP Certificate.
2002
- The company entered new global markets.
2003
- The manufacturing unit was approved by the Nigeria Food and Drug Administration.
2004
- The Daman manufacturing unit started manufacturing.
- The company established a Quality Management System compliant with ISO 9001:2008.
2005
- The company received a WHO GMP Certificate for the Daman Plant.
- The company started contract manufacturing for ACI Pharm and Medicale Pharmaceutique.
- The company received an ISO 9001-2008 Certificate for the Daman plant.
2006
- The company started the Dehradun plant.
2009
- The company received a WHO GMP Certificate for the Dehradun Plant.
2011
- Coral Laboratories Ltd recommended a dividend of 15%.
2012
- Coral Laboratories Ltd recommended a dividend of 15%.
2013
- Coral Laboratories Ltd recommended a final dividend of 15%.
2014
- Coral Laboratories Ltd recommended a dividend of 20%.
Open Your Free Demat Account Now!
Facebook
Twitter
Instagram
LinkedIn
Youtube
Calculators
Popular Calculators
Group Stocks
Pocketful Fintech Capital Private Limited (CIN U65999DL2021PTC390548) | The SEBI Registration No. allotted to us is INZ000313732. NSE Member Code: 90326 | BSE Member Code: 6808 | MCX Member Code: 57120 DP | CDSL: 12099800